Yervoi 50mg

verified
Sourced from: Manufacturer Authorized Distributor
Marketer Bristol Myers Squibb
Composition Ipilimumab
Storage 2 - 8
Packaging Type Box of 50mg vial
MRP 79750
Alternate Medicines

Overview

Yervoi 50mg Injection contains active component as Ipilimumab. This medication is used to treat advanced melanoma (a type of skin cancer) that has spread to other parts of the body. It can treat cancer of the lungs, liver, and kidneys in adults. Also used to treat colorectal cancer in adults and children (12 years and older). Cancer is a disorder in which cells multiply uncontrolled and abnormally. Talk to your physician if you have immune system problems (such as ulcerative colitis, Crohn’s disease, lupus, or sarcoidosis), liver problems, a history of inflammation of the lungs, HIV (human immunodeficiency syndrome) infection, or have had an organ transplant before taking Yervoi 50mg Injection.

Like many cancer treatments, Yervoi 50mg Injection can cause side effects, including fatigue, diarrhea, and skin rash, but these side effects are typically manageable with appropriate medical care. The main benefit of Yervoi 50mg Injection is that it can help improve survival in patients with advanced melanoma. Another benefit is it targets the immune system, so it is less toxic to healthy cells than other cancer treatments, such as chemotherapy or radiation therapy